Clinical Trial Update: Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial compares metabolic effects of boosted protease inhibitor regimens—atazanavir/ritonavir versus darunavir/ritonavir—each with Tenofovir/Emtrici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-1

Drugs mentioned

• Emtriva (emtricitabine)
• Norvir (ritonavir)
• PREZISTA (darunavir)
• REYATAZ (atazanavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: HIV-1 | Phase 4 | Status: COMPLETED